Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05642195 |
|---|---|
| Brief Title: | Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer |
| First Submitted : | December 6, 2022 |
| First Submitted that Met QC Criteria : | December 7, 2022 |
| First Posted : | December 8, 2022 |
| Last Update Submitted that Met QC Criteria : | May 17, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |